Cited by 177Diabetes Management and ResearchDiabetic Foot Ulcer Assessment and ManagementRetinal Diseases and Treatments

12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes—2022

Open access
American Diabetes Association Professional Practice Committee·2022·Diabetes Care

Abstract

The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc22-s012

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prior to autonomous AI testing, all patients were referred to ophthalmology for an annual eye examination.

    “Prior to autonomous AI testing, all patients were referred to ophthalmology for an annual eye examination.59”

    From Autonomous Artificial Intelligence in Diabetic Retinopathy Testing—Lessons Learned on Successful Health System Adoption (2026) · cites this paper as [59]

    Section 12.3 recommends eye examinations that are generally repeated annually and permits examination by an ophthalmologist or optometrist. It does not establish that, before autonomous AI testing, all patients were referred to ophthalmology for annual examinations; it also allows 1–2-year screening intervals for some patients. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Amidst rising DR prevalence, autonomous AI testing presents a promising solution to facilitate early detection, promote equitable access, and drive down system-level cost of care.

    “Amidst rising DR prevalence, autonomous AI testing presents a promising solution to facilitate early detection, promote equitable access, and drive down system-level cost of care.42,48,67”

    From Autonomous Artificial Intelligence in Diabetic Retinopathy Testing—Lessons Learned on Successful Health System Adoption (2026) · cites this paper as [42]

    Section 12.3 identifies FDA-authorized AI systems as an alternative for diabetic-retinopathy screening and explains why prompt detection matters. It attributes improved access and possible cost savings to retinal photography with remote expert reading, not specifically to autonomous AI, and says the benefits and optimal use of AI screening remain undetermined. The cited passages do not establish rising retinopathy prevalence. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • In the KDIGO and ADA algorithms, the diagnosis of moderately increased or severely increased albuminuria requires increased albumin excretion on two of three tests repeated over 3 to 6 months and exclusion of conditions that invalidate the test.

    “In the KDIGO and ADA algorithms for urine albumin testing (506), the diagnosis of moderately increased or severely increased albuminuria requires the demonstration of increased albumin excretion on two of three tests repeated at intervals over a period of 3 to 6 months and exclusion of conditions that invalidate the test.”

    From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [506]

    Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Stanford University found that those referred after an AI-based examination followed up at the eye institute at a rate nearly 3 times higher than those referred after teleophthalmology-only testing.

    “In the same study as previously mentioned, Stanford University found that those referred after an AI-based examination followed up at the eye institute at a rate nearly 3 times higher than those referred after teleophthalmology-only testing.42”

    From Autonomous Artificial Intelligence in Diabetic Retinopathy Testing—Lessons Learned on Successful Health System Adoption (2026) · cites this paper as [42]

    Section 12.3 discusses AI-based retinal screening and follow-up after abnormal results, but it does not report a Stanford study or compare follow-up rates after AI-based and teleophthalmology-only examinations. Searches for the claimed study and the nearly threefold follow-up difference found no matching passage in our copy. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [32]32. Sivaprasad S, Prevost AT, Vasconcelos JC, et al.; CLARITY Study Group. Clinical efficacy of Complications study (DCCT/EDIC). Circulation 2009;119:2886-2893

Cited by

Sorted by citations

Authors
American Diabetes Association Professional Practice Committee
Corresponding author
American Diabetes Association Professional Practice Committee
Venue
Diabetes Care
Published
2021-12-16
Volume
45
Issue
Supplement_1
Pages
S185-S194
ISSN
0149-5992 (ISSN-L)
OpenAlex
W4200289220
Cited by
177
References
95
Citations by year
2026: 12 · 2025: 24 · 2024: 40 · 2023: 60 · 2022: 41
FWCI
5.40
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
diabetic retinopathy, diabetic neuropathy, diabetic foot care, diabetes complications, clinical guidelines, quality of care
MeSH terms
Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Retinal Diseases, Societies, Medical, Standard of Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review